Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac Launches 2008-2009 Version of Flu Vaccine

publication date: Sep 11, 2008

Sinovac Biotech announced the launch of the 2008-2009 version of its seasonal flu vaccine, Anflu®. Anflu is the only split influenza vaccine produced without preservatives in China. Sinovac said it would market the vaccine to adults. Last year, Sinovac signed a co-promotion agreement with GlaxoSmithKline under which Sinovac was responsible for marketing Anflu to children, while GSK took over the duty for adults. More details...

Stock Symbols: (AMEX: SVA) (NYSE: GSK)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital